Oaktree Acquisition Corp III Life Sciences
OACC
39 hedge funds and large institutions have $153M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.
475% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 4
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
95% more funds holding
Funds holding: 20 → 39 (+19)
71% more capital invested
Capital invested by funds: $89.8M → $153M (+$63.4M)
30.36% more ownership
Funds ownership: 45.45% → 75.81% (+30%)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.03M |
| 2 |
D.E. Shaw & Co
New York
|
+$8.65M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$7.03M |
| 4 |
LA
Linden Advisors
New York
|
+$6.02M |
| 5 |
Goldman Sachs
New York
|
+$5.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$9.54M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$5.31M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$4.5M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$3.01M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$533K |
OACC Hedge Fund Activity: Q1 2025 in Review
39 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences (OACC) for Q1 2025, worth a combined $153M — up 71% from $89.8M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new OACC positions and 4 closed out — a net gain of 19 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $9.03M. The largest seller was Toronto Dominion Bank, cutting an estimated $9.54M.
- 39 institutional investors held Oaktree Acquisition Corp III Life Sciences (OACC) as of Q1 2025, up from 20 in Q4 2024.
- Funds reported $153M of Oaktree Acquisition Corp III Life Sciences stock for Q1 2025, up 71% quarter-over-quarter.
- 23 funds opened new Oaktree Acquisition Corp III Life Sciences positions in Q1 2025 and 4 closed out, a net change of +19 holders.
- The largest Oaktree Acquisition Corp III Life Sciences buyer in Q1 2025 was Driehaus Capital Management, an estimated $9.03M added.
- The largest Oaktree Acquisition Corp III Life Sciences seller in Q1 2025 was Toronto Dominion Bank, an estimated $9.54M sold.
Based on aggregated 13F filings for Q1 2025.